SEC Form 13F Summary: Genworth Financial Inc
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Genworth Financial Inc for the reporting period ending June 30, 2023. The form discloses the company's holdings of equity securities as required by the Securities and Exchange Commission.
Key Financial Metrics and Holdings
The filing does not provide Genworth Financial Inc's own revenue, profit, cash flow, or debt metrics. Instead, it lists specific equity positions held by the company. The total value of the reported holdings in this excerpt is approximately $300.3 million.
| Issuer Name | Title of Class | Shares Held | Value (USD) | Voting Authority |
|---|---|---|---|---|
| ISHARES CORE S&P 500 INDEX ETF | COM | 601,470 | $268,081,194 | Sole |
| POWERSHARES S&P 500 LOW VOLATILITY COM | COM | 446,687 | $28,056,410 | Sole |
| MIRUM PHARMACEUTICALS INC | COM | 11,939 | $308,862 | Sole |
| ARCELLX INC | COM | 1,791 | $56,631 | Sole |
Material Changes and Outlook
The filing text does not provide comparative data for prior periods, management commentary, guidance, or risk factors. Consequently, material changes versus the prior period and future outlook cannot be determined from this document.
Investor Verification Checklist
- Verify the total aggregate value of all holdings reported in the full Form 13F, as this excerpt may not represent the entire portfolio.
- Confirm the specific CUSIP numbers for the listed securities to ensure accurate identification.
- Review the company's 10-Q or 10-K filings for actual financial performance metrics (revenue, profit, debt) which are not included in Form 13F.
- Check for any subsequent filings that may have updated these positions as of the current date.